{"title":"在妊娠糖尿病患者中发现新的ChAT基因错义变异表明可能的遗传关联。","authors":"Oluwafemi G Oluwole, Afolake Arowolo, Ezekiel Musa, Naomi Levitt, Mushi Matjila","doi":"10.1515/med-2025-1225","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Gestational diabetes mellitus (GDM), the most common metabolic complication of pregnancy, is associated with a 50% increase in subsequent risk for type 2 diabetes. There is increasing interest in identifying biomarkers that may facilitate the stratification of subsequent type 2 diabetes risk among women with GDM. In this study, we considered the choline acetyltransferase (<i>ChAT</i>) gene. CHAT plays a critical role in acetylcholine synthesis and regulates insulin secretion from the pancreatic islet to maintain glucose homeostasis.</p><p><strong>Methods: </strong>We screened for deleterious variants in the <i>ChAT</i> gene in 12 GDM patients and 10 ethnically matched controls from a South African cohort. We isolated DNA from the placental samples of these patients and performed DNA sequencing of the protein-coding region of the <i>ChAT</i> gene. Sequence alignments and variant annotations were done using UGENE software and Ensembl VEP.</p><p><strong>Results: </strong>A novel heterozygous missense variant in exon 8 of the <i>ChAT</i> gene was identified. The plausible phenotypic impact of the variant <i>ChAT</i> (NM_020549.5):c.1213C>G (p.Leu405Val) can be explained by haploinsufficiency, changing protein activities, strong transcription activity, and epigenetic repression activities of the variant. Also, structurally, the variant is located 18bp in-frame to a stop-gained variant (p.Gly411Ter). The RegulomeDB DNase expression data clearly show the identified variant in a peak expression in the spleen and placenta. This observation corroborates that the <i>ChAT</i> gene may play an essential role in GDM.</p><p><strong>Conclusion: </strong>Taken together, the metric scores for this variant show that it could affect the functions of the gene, but more functional studies are necessary to validate these effects. Consequently, this study sets the stage for the future screening of a larger cohort and functional validation of deleterious variants to underpin the <i>ChAT</i> gene and GDM association.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20251225"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273656/pdf/","citationCount":"0","resultStr":"{\"title\":\"The identification of novel missense variant in <i>ChAT</i> gene in a patient with gestational diabetes denotes plausible genetic association.\",\"authors\":\"Oluwafemi G Oluwole, Afolake Arowolo, Ezekiel Musa, Naomi Levitt, Mushi Matjila\",\"doi\":\"10.1515/med-2025-1225\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Gestational diabetes mellitus (GDM), the most common metabolic complication of pregnancy, is associated with a 50% increase in subsequent risk for type 2 diabetes. There is increasing interest in identifying biomarkers that may facilitate the stratification of subsequent type 2 diabetes risk among women with GDM. In this study, we considered the choline acetyltransferase (<i>ChAT</i>) gene. CHAT plays a critical role in acetylcholine synthesis and regulates insulin secretion from the pancreatic islet to maintain glucose homeostasis.</p><p><strong>Methods: </strong>We screened for deleterious variants in the <i>ChAT</i> gene in 12 GDM patients and 10 ethnically matched controls from a South African cohort. We isolated DNA from the placental samples of these patients and performed DNA sequencing of the protein-coding region of the <i>ChAT</i> gene. Sequence alignments and variant annotations were done using UGENE software and Ensembl VEP.</p><p><strong>Results: </strong>A novel heterozygous missense variant in exon 8 of the <i>ChAT</i> gene was identified. The plausible phenotypic impact of the variant <i>ChAT</i> (NM_020549.5):c.1213C>G (p.Leu405Val) can be explained by haploinsufficiency, changing protein activities, strong transcription activity, and epigenetic repression activities of the variant. Also, structurally, the variant is located 18bp in-frame to a stop-gained variant (p.Gly411Ter). The RegulomeDB DNase expression data clearly show the identified variant in a peak expression in the spleen and placenta. This observation corroborates that the <i>ChAT</i> gene may play an essential role in GDM.</p><p><strong>Conclusion: </strong>Taken together, the metric scores for this variant show that it could affect the functions of the gene, but more functional studies are necessary to validate these effects. Consequently, this study sets the stage for the future screening of a larger cohort and functional validation of deleterious variants to underpin the <i>ChAT</i> gene and GDM association.</p>\",\"PeriodicalId\":19715,\"journal\":{\"name\":\"Open Medicine\",\"volume\":\"20 1\",\"pages\":\"20251225\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273656/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1515/med-2025-1225\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/med-2025-1225","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
妊娠期糖尿病(GDM)是妊娠期最常见的代谢并发症,与随后发生2型糖尿病的风险增加50%相关。人们对识别生物标记物越来越感兴趣,这些生物标记物可能促进GDM女性随后2型糖尿病风险的分层。在这项研究中,我们考虑了胆碱乙酰转移酶(ChAT)基因。CHAT在乙酰胆碱合成中起关键作用,并调节胰岛胰岛素分泌以维持葡萄糖稳态。方法:我们筛选了来自南非队列的12名GDM患者和10名种族匹配对照者的ChAT基因有害变异。我们从这些患者的胎盘样本中分离DNA,并对ChAT基因的蛋白质编码区进行DNA测序。序列比对和变体注释使用UGENE软件和Ensembl VEP完成。结果:在ChAT基因外显子8上发现了一个新的杂合错义变异。变异ChAT (NM_020549.5)可能的表型影响:1213C b> G (p.l u405val)可以通过变异的单倍不全、改变蛋白活性、强转录活性和表观遗传抑制活性来解释。此外,在结构上,该变体位于帧内18bp的停止增益变体(p.Gly411Ter)。RegulomeDB dna酶表达数据清楚地显示,鉴定的变异在脾脏和胎盘中的表达达到峰值。这一观察结果证实了ChAT基因可能在GDM中起重要作用。结论:综上所述,该变异的度量分数表明它可能影响基因的功能,但需要更多的功能研究来验证这些影响。因此,这项研究为未来更大的队列筛选和有害变异的功能验证奠定了基础,以支持ChAT基因和GDM的关联。
The identification of novel missense variant in ChAT gene in a patient with gestational diabetes denotes plausible genetic association.
Introduction: Gestational diabetes mellitus (GDM), the most common metabolic complication of pregnancy, is associated with a 50% increase in subsequent risk for type 2 diabetes. There is increasing interest in identifying biomarkers that may facilitate the stratification of subsequent type 2 diabetes risk among women with GDM. In this study, we considered the choline acetyltransferase (ChAT) gene. CHAT plays a critical role in acetylcholine synthesis and regulates insulin secretion from the pancreatic islet to maintain glucose homeostasis.
Methods: We screened for deleterious variants in the ChAT gene in 12 GDM patients and 10 ethnically matched controls from a South African cohort. We isolated DNA from the placental samples of these patients and performed DNA sequencing of the protein-coding region of the ChAT gene. Sequence alignments and variant annotations were done using UGENE software and Ensembl VEP.
Results: A novel heterozygous missense variant in exon 8 of the ChAT gene was identified. The plausible phenotypic impact of the variant ChAT (NM_020549.5):c.1213C>G (p.Leu405Val) can be explained by haploinsufficiency, changing protein activities, strong transcription activity, and epigenetic repression activities of the variant. Also, structurally, the variant is located 18bp in-frame to a stop-gained variant (p.Gly411Ter). The RegulomeDB DNase expression data clearly show the identified variant in a peak expression in the spleen and placenta. This observation corroborates that the ChAT gene may play an essential role in GDM.
Conclusion: Taken together, the metric scores for this variant show that it could affect the functions of the gene, but more functional studies are necessary to validate these effects. Consequently, this study sets the stage for the future screening of a larger cohort and functional validation of deleterious variants to underpin the ChAT gene and GDM association.
期刊介绍:
Open Medicine is an open access journal that provides users with free, instant, and continued access to all content worldwide. The primary goal of the journal has always been a focus on maintaining the high quality of its published content. Its mission is to facilitate the exchange of ideas between medical science researchers from different countries. Papers connected to all fields of medicine and public health are welcomed. Open Medicine accepts submissions of research articles, reviews, case reports, letters to editor and book reviews.